Cargando…
Assessing the legal duty to use or disclose interim data for ongoing clinical trials
Randomized controlled clinical trials, leading to large-scale meta-analyses, are considered the gold standard for research evaluating new drugs and other therapeutic interventions. To promote scientific integrity and prevent the adoption of potentially fallacious early trends, emerging information i...
Autor principal: | Eckstein, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813938/ https://www.ncbi.nlm.nih.gov/pubmed/31666965 http://dx.doi.org/10.1093/jlb/lsz012 |
Ejemplares similares
-
Analyzing genomes: is there a duty to disclose?
por: McGuire, Amy
Publicado: (2012) -
Legal Disputes over Duties to Disclose Treatment Risks to Patients: A Review of Negligence Claims and Complaints in Australia
por: Bismark, Marie M., et al.
Publicado: (2012) -
The Legal Duties of Hospital Governors
Publicado: (1913) -
Professional duties are now considered legal duties of care within genomic medicine
por: Anna, Middleton, et al.
Publicado: (2020) -
The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
por: de Boniface, Jana, et al.
Publicado: (2020)